TIME, a Phase 2b/3 Study Evaluating TG4010 in Combination With First-Line Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC): Phase 2b Results

Affiliation auteurs!!!! Error affiliation !!!!
TitreTIME, a Phase 2b/3 Study Evaluating TG4010 in Combination With First-Line Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC): Phase 2b Results
Type de publicationJournal Article
Year of Publication2014
AuteursQuoix E., Losonczy G., Forget F., Chouaid C., Papai Z., Gervais R., Ottensmeier C., Szczesna A., Kazarnowicz A., Beck J.T, Westeel V., Vanderheyde K., Lacoste G., Bastien B., Halluard C., Marchand S., Limacher J.M, Lena H.
JournalINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Volume90
PaginationS35
Date PublishedNOV 15
Type of ArticleMeeting Abstract
ISSN0360-3016
DOI10.1016/j.ijrobp.2014.08.211